Article info
Response
Palliative opioid use, palliative sedation and euthanasia: reaffirming the distinction
- Correspondence to Dr Guy Schofield, University of Bristol Centre for Ethics in Medicine, Bristol BS8 2PS, UK; guy.schofield{at}bristol.ac.uk
Citation
Palliative opioid use, palliative sedation and euthanasia: reaffirming the distinction
Publication history
- Received November 12, 2018
- Revised May 8, 2019
- Accepted May 12, 2019
- First published June 20, 2019.
Online issue publication
January 14, 2020
Article Versions
- Previous version (20 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- A response to critics: weakening the ethical distinction between euthanasia, palliative opioid use and palliative sedation
- Terminal sedation and the “imminence condition”
- Weakening the ethical distinction between euthanasia, palliative opioid use and palliative sedation
- Approaches to suffering at the end of life: the use of sedation in the USA and Netherlands
- Euthanasia and palliative sedation in Belgium
- Ethical end-of-life palliative care: response to Riisfeldt
- Strengthening the ethical distinction between euthanasia, palliative opioid use and palliative sedation
- Moral differences in deep continuous palliative sedation and euthanasia
- Palliative sedation determinants: systematic review and meta-analysis in palliative medicine
- Expanded terminal sedation in end-of-life care